Incyte | INCY - EPS Earnings Per Share

Incyte reported $1.06 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.

Fiscal Calendar Actual Consensus Previous Date
FY2024Q1 Mar/2024 0.88 0.37 Apr/30 2024
FY2023Q4 Dec/2023 1.06 1.14 0.62 Feb/13 2024
FY2023Q3 Sep/2023 0.76 0.88 0.60 Oct/31 2023
FY2023Q2 Jun/2023 0.99 0.79 1.01 Aug/01 2023
FY2023Q1 Mar/2023 0.37 0.75 0.55 May/02 2023
FY2022Q4 Dec/2022 0.62 0.57 0.1 Feb/07 2023
FY2022Q3 Sep/2022 0.6 0.71 1.18 Nov/01 2022
FY2022Q2 Jun/2022 1.01 0.80 0.8 Aug/02 2022
FY2022Q1 Mar/2022 0.55 0.67 0.67 May/03 2022
FY2021Q4 Dec/2021 0.1 0.85 0.93 Feb/08 2022
FY2021Q3 Sep/2021 1.18 0.75 0.23 Nov/02 2021
FY2021Q2 Jun/2021 0.8 0.76 1.24 Aug/03 2021

Eps Change Date
Acadia Pharmaceuticals USD 0.28 0.68 Dec/2023
Agios Pharmaceuticals USD -1.72 0.08 Dec/2023
Alnylam Pharmaceuticals USD -1.1 2.25 Dec/2023
Amgen USD 4.71 0.25 Dec/2023
Biogen USD 3.67 0.37 Mar/2024
BioMarin Pharmaceutical USD 0.71 0.53 Mar/2024
Bristol-Myers Squibb USD -4.4 6.1 Mar/2024
Eli Lilly USD 2.49 2.39 Dec/2023
Exelixis USD 0.27 0.17 Dec/2023
Gilead Sciences USD 1.72 0.57 Dec/2023
Incyte USD 1.06 0.04 Dec/2023
Ionis Pharmaceuticals USD -0.06 0.97 Dec/2023
MacroGenics USD -0.75 1.03 Dec/2023
Merck USD 2.07 2.04 Mar/2024
Moderna USD 0.55 10.08 Dec/2023
Neurocrine Biosciences USD 1.44 0.62 Dec/2023
Novartis USD 1.8 0.27 Mar/2024
Novartis USD 1.53 0.3 Dec/2023
Pfizer USD 0.1 0.27 Dec/2023
PTC Therapeutics USD -1.2 0.96 Mar/2024
Regeneron Pharmaceuticals USD 11.86 0.27 Dec/2023
Sarepta Therapeutics USD 0.47 0.93 Dec/2023
Ultragenyx Pharmaceutical USD -1.52 0.71 Dec/2023
Vertex Pharmaceuticals USD 4.2 0.12 Dec/2023